×
Innoviva SG&A Expenses 2010-2025 | INVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Innoviva sg&a expenses from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
View More
Innoviva SG&A Expenses 2010-2025 | INVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Innoviva sg&a expenses from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$796.4B
Johnson & Johnson (JNJ)
$379.5B
AbbVie (ABBV)
$306B
Novo Nordisk (NVO)
$260.6B
Roche Holding AG (RHHBY)
$248.1B
Novartis AG (NVS)
$234.2B
Merck (MRK)
$196.7B
Sanofi (SNY)
$128.6B
Pfizer (PFE)
$125.6B
Bayer (BAYRY)
$23.7B